ArticleJournal of multidisciplinary healthcare2026
Transcranial Magnetic Stimulation Combined with Nursing Intervention in Children with Autism Spectrum Disorder and Its Effects on Developmental Quotient and Serum Neurotransmitters.
Article in Journal of multidisciplinary healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the clinical efficacy and potential biological effects of transcranial magnetic stimulation (TMS) combined with rehabilitation nursing in children with autism spectrum disorder (ASD). Methods: This retrospective controlled study included 90 children with ASD admitted between January 2023 and January 2025. Participants were divided into a control group (rehabilitation nursing only, n = 45) and an observation group (TMS combined with rehabilitation nursing, n = 45). Outcomes included Developmental Quotient assessed by the Gesell Developmental Schedules, autism-related behaviors assessed by the Autism Behavior Checklist, symptom severity assessed by the Autism Treatment Evaluation Checklist, quality of life assessed by the Pediatric Quality of Life Inventory, and serum neurotransmitter levels [glutamate (Glu) and γ-aminobutyric acid (GABA)]. Results: After intervention, both groups showed significant improvements in developmental quotient and quality of life, along with reductions in autism-related behaviors and symptom severity (all P < 0.05). Improvements were consistently greater in the observation group compared with the control group. In addition, serum Glu and GABA levels increased significantly after intervention in both groups, with a greater magnitude of change observed in the observation group (P < 0.05). Conclusion: TMS combined with rehabilitation nursing may effectively promote developmental progress, alleviate behavioral symptoms, and improve quality of life in children with ASD, accompanied by increased serum Glu and GABA levels. These findings suggest that TMS may serve as a promising adjunctive intervention. Further multicenter randomized controlled trials with long-term follow-up are warranted to confirm efficacy, optimize stimulation parameters, and explore underlying mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.